Search tips
Search criteria 


Logo of diabetesSubscribeSearchDiabetes JournalAmerican Diabetes Association
Diabetes. 2010 January; 59(1): 319.
PMCID: PMC2797939


Gentile MT, Vecchione C, Marino G, Aretini A, Di Pardo A, Antenucci G, Maffei A, Cifelli G, Iorio L, Landolfi A, Frati G, Lembo G. Resistin impairs insulin-evoked vasodilation. Diabetes 2008;57:577–583

In the research design and methods subsection “Chronic resistin treatment” in the print version of the article listed above, the in vivo dose used in the experiment is reported incorrectly in the sentence “In some mice, resistin (1 μg/min) or vehicle was administered chronically for 28 days by osmotic minipumps implanted subcutaneously (Alzet).” The correct in vivo dose is 1 μg/day. The online version reflects these changes.

Articles from Diabetes are provided here courtesy of American Diabetes Association